NUCYNTA
LOE Approachingtapentadol hydrochloride
NDAORALSOLUTION
Approved
Oct 2012
Lifecycle
LOE Approaching
Competitive Pressure
35/100
Clinical Trials
3
Clinical Trials (3)
A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain
Started Oct 2014
0Moderate to Severe Acute Non-Cancer Pain
A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain
Started Oct 2014
0Moderate to Severe Chronic Non-cancer Pain
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
Started Sep 2009
667 enrolled
PainBack PainLow Back Pain+1 more
Loss of Exclusivity
LOE Date
Jul 3, 2026
4 months away
Exclusivity Expiry
Jan 3, 2027